Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway

Kevin Guo(The University of Texas MD Anderson Cancer Center), Hong Zhang(Memorial Sloan Kettering Cancer Center)
Oncotarget
December 12, 2017
Cited by 20


Related Papers